EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation

Zhenjia Fan, Luqing Zhao, Ning Ding, Yichong Wang, Danyan Li, Shengsheng Zhang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-10 · 399 (13) · 21667-21684

DOI: 10.1007/s00210-026-05737-4 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 25.07.2026. Verfasst von Zhenjia Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, NF-E2-Related Factor 2, Quercetin, Cyclooxygenase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a worldwide health issue with limited therapies. Traditional Chinese Medicine (TCM) shows potential, but lacks systematic efficacy evaluation and detailed mechanistic explanations. This study aims to evaluate the efficacy of TCM for active UC and explore its mechanisms. A meta-analysis of RCTs was conducted to assess TCM efficacy in active UC, and treatment efficacy was ranked. Core Chinese herbs were identified via association rule analysis. Network pharmacology and molecular docking predicted active components, targets, and pathways. Efficacy of the key component was validated in active UC mice. 17 studies (1,598 patients) showed TCM significantly improved active UC (SMD -1.73, 95%CI -2.21 to -1.25). Eight core Chinese herbs were identified. Network pharmacology revealed 76 overlapping targets. Isorhamnetin (Iso) showed strong binding to PTGS2 (binding energy: -9.34 kcal/mol) and Nrf2 (binding energy: -9.16 kcal/mol). In vivo, Iso dose-dependently alleviated disease symptoms, pathological damage, and spleen index in UC mice. TCM could ameliorate active UC. The key active component Iso shows therapeutic effects, with mechanisms potentially involving the Nrf2-PTGS2 axis and immune-inflammatory pathways. The findings offer some insight into the scientific basis of TCM in treating UC and predict that Iso may be a candidate for further mechanistic and clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeNF-E2-Related Factor 2QuercetinCyclooxygenase 2Drugs, Chinese HerbalAnti-Inflammatory AgentsAnimalsHumansMolecular Docking SimulationMiceNetwork Pharmacology

Stichwörter der Autor:innen

IsorhamnetinMeta‐analysisNetwork pharmacologyTCMUlcerative colitis

Substanzen

NF-E2-Related Factor 2QuercetinCyclooxygenase 23-methylquercetinDrugs, Chinese HerbalPtgs2 protein, mouseAnti-Inflammatory AgentsNFE2L2 protein, humanNfe2l2 protein, mousePTGS2 protein, human

Autor:innen und Institutionen

  • Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
  • Intensive Care Unit, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
  • Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China. zhangshengsheng@bjzhongyi.com.

Zitieren

APA

Fan, Z., Zhao, L., Ding, N., Wang, Y., Li, D., & Zhang, S. (2026). Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(13), 21667-21684. https://doi.org/10.1007/s00210-026-05737-4

Vancouver

Fan Z, Zhao L, Ding N, Wang Y, Li D, Zhang S. Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(13):21667-21684. doi:10.1007/s00210-026-05737-4

BibTeX
@article{Fan2026,
  author = {Fan, Zhenjia and Zhao, Luqing and Ding, Ning and Wang, Yichong and Li, Danyan and Zhang, Shengsheng},
  title = {Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {13},
  pages = {21667--21684},
  doi = {10.1007/s00210-026-05737-4}
}
Kostenlos starten →